Agenesis of Corpus Callosum: Clinical Trials

21 trials for Agenesis of Corpus Callosum, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 4 unknown, 3 recruiting, 1 not yet recruiting. 4 Not applicable, 1 Early Phase 1, 1 Phase 1, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 3, Unknown 1
Early Phase 11Completed 1
Phase 11Not yet recruiting 1
Phase 31Recruiting 1
Phase 41Completed 1

Follow Agenesis of Corpus Callosum: new trials by email Literature Review of Agenesis of Corpus Callosum trials Research Report on Agenesis of Corpus Callosum

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bioengineered Penile Tissue Constructs for Irreversibly Damaged Penile Corpora
Autologous tissue engineered corpora - Urologic Diseases, Male Urogenital Diseases
Phase 1Not yet recruitingWake Forest University Health Sciences102026-10-012026-03-27
A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
Setmelanotide, Placebo - Hypothalamic Obesity, Multiple Pituitary Hormone Deficiency Genetic Form
Phase 3RecruitingRhythm Pharmaceuticals, Inc.392025-09-232026-02-12
Sleep Profile of Patients With Septo-optic Dysplasia
Actigraphy, blood and salivary sample, and sleep evaluation - Septo-Optic Dysplasia, Agenesis of Corpus Callosum
UnknownIRCCS National Neurological Institute "C. Mondino" Foundation452023-12-202024-02-15
Decision-making Process of Couples Confronted With Prenatal Diagnosis of an Isolated CCA
Decision-making process - Corpus Callosum Agenesis
Not applicableUnknownAssistance Publique - Hôpitaux de Paris1002021-10-222023-05-06
Retrospective Study Using Next Generation Sequencing (NGS) on Biological Samples to Improve Genetic Counseling for Patients With Previously Explored Craniofacial Midline Defects.
NGS - Holoprosencephaly
CompletedRennes University Hospital332021-02-102021-12-07
Screening of Septo-optic Dysplasia During a Fetal Examination at 16-20 Weeks of Gestation
Displaying optic chiasm for screening septooptic dysplasia - 2D Ultrasound, Cavum Septum Pellucidum
Not applicableCompletedGaziosmanpasa Research and Education Hospital522020-09-212023-02-08
Whole Exome Sequencing in Prenatal Diagnosis of Agenesis of the Corpus Callosum
whole exome sequencing (WES) - Fetal Agenesis of the Corpus Callosum (ACC)
CompletedAssistance Publique - Hôpitaux de Paris312018-08-282021-01-19
Frequency and Type of Genetic Abnormalities Found in Antenatal Corpus Callosum Malformation
Corpus Callosum Malformation, Prenatal Disorder
UnknownUniversity Hospital, Brest2752018-06-182018-09-21
BECOME CHILDREN OF HOLDERS Corpus Callosum Agenesis Screened IN PERIOD Antenatal
Corpus Callosum Agenesis
UnknownUniversity Hospital, Strasbourg, France602016-07-012017-05-22
Infants With Agenesis of the Corpus Callosum
Psychometric scales for infants at 3 years of age - Agenesis of the Corpus Callosum
Not applicableCompletedAssistance Publique - Hôpitaux de Paris722015-09-262026-03-31
Impact of Interictal Electroencephalographic Abnormalities on the Stability of Attention in the Epilepsies
abnormal EEGs - Epilepsy
Not applicableCompletedUniversity Hospital, Grenoble1622015-05-012023-10-18
Corpus Callosum Agenesis and Intellectual Disability
Genetic - Intellectual Deficiency, Cerebral Abnormality
CompletedAssistance Publique - Hôpitaux de Paris3602012-01-012014-06-19
The Natural History of Mucolipidosis Type IV
Mucolipidosis Type IV
TerminatedBaylor Research Institute72009-02-192026-01-26
Biological Clock Dysfunction in Optic Nerve Hypoplasia
Melatonin, Placebo Comparator - Biological Clock Dysfunction, Optic Nerve Hypoplasia
Early Phase 1CompletedYale University1002008-10-012020-09-25
A Study of the Genetic Analysis of Brain Disorders
Holoprosencephaly
CompletedNational Human Genome Research Institute (NHGRI)57352008-06-012021-12-14
Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia
Nutropin AQ - Growth Hormone Deficiency, Septo-Optic Dysplasia
Phase 4CompletedChildren's Hospital Los Angeles202004-12-012015-04-01
Clinical and Genetic Studies on Holoprosencephaly
Holoprosencephaly, HPE
CompletedNational Human Genome Research Institute (NHGRI)2562004-01-232020-04-20
Brain Development Research Program
Brain Disorders, Aicardi Syndrome
RecruitingUniversity of California, San Francisco20002003-08-012026-08-17
Study of Selected X-Linked Disorders: Aicardi Syndrome
Syndrome cause identification - Aicardi Syndrome, Brain Disorders
RecruitingBaylor College of Medicine5002002-10-012026-05-05
Study of the Experiences and Needs of Parents Continuing a Pregnancy Following a Prenatal Diagnosis of Holopresencephaly
Holoprosencephaly
CompletedNational Human Genome Research Institute (NHGRI)302000-03-012008-03-04

Showing 20 of 21. Sign in to see all of them.

Narrower conditions

Holoprosencephaly (5)  ·  Septo-Optic Dysplasia (5)  ·  Aicardi Syndrome (3)  ·  Brain Diseases (3)  ·  Congenital Abnormalities (3)  ·  Optic Nerve Hypoplasia (3)  ·  Epilepsy (2)  ·  Intellectual Disability (2)  ·  Accidental Injuries (1)  ·  Autistic Disorder (1)  ·  Blindness (1)  ·  Corneal Opacity (1)  ·  Demyelinating Diseases (1)  ·  Developmental Disabilities (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (21)  ·  Nervous System Diseases (21)  ·  Nervous System Malformations (21)  ·  Congenital Abnormalities (18)  ·  Genetic Diseases, Inborn (11)  ·  Pathological Conditions, Anatomical (10)  ·  Pathological Conditions, Signs and Symptoms (10)  ·  Eye Diseases (9)  ·  Musculoskeletal Diseases (7)  ·  Central Nervous System Diseases (6)  ·  Eye Diseases, Hereditary (6)  ·  Abnormalities, Multiple (5)  ·  Chromosome Disorders (5)  ·  Congenital Cranial Dysinnervation Disorders (5)

Interventions

Actigraphy (1)  ·  Aging (1)  ·  Blood Specimen Collection (1)  ·  Exome Sequencing (1)  ·  Growth Hormone (1)  ·  Melatonin (1)  ·  setmelanotide (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (4)  ·  National Human Genome Research Institute (NHGRI) (4)  ·  Baylor College of Medicine (1)  ·  Baylor Research Institute (1)  ·  Children's Hospital Los Angeles (1)  ·  Gaziosmanpasa Research and Education Hospital (1)  ·  IRCCS National Neurological Institute "C. Mondino" Foundation (1)  ·  Rennes University Hospital (1)  ·  Rhythm Pharmaceuticals, Inc. (1)  ·  University Hospital, Brest (1)  ·  University Hospital, Grenoble (1)  ·  University Hospital, Strasbourg, France (1)  ·  University of California, San Francisco (1)  ·  Wake Forest University Health Sciences (1)  ·  Yale University (1)

Countries

United States (11)  ·  France (8)  ·  Italy (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Benjamin D Solomon, M.D. (1)  ·  Casandra Fink (1)  ·  David Meeker, MD (1)  ·  Elliott H Sherr, MD, PhD (1)  ·  James Barkovich, MD (1)  ·  Jean-Marie Jouannic, MD, PhD (1)  ·  Mark Borchert, MD (1)  ·  Mitchell Geffner, MD (1)  ·  Paul S Kruszka, M.D. (1)

Results publications

PMID 10739772, PMID 14738943, PMID 16158440, PMID 16275846, PMID 17056927, PMID 17375041, PMID 17546030, PMID 17621479, PMID 17632789, PMID 17668379, PMID 18925666, PMID 19001538, PMID 19116729, PMID 19246528, PMID 19760649, PMID 20206699, PMID 20610117, PMID 20683985, PMID 22681940, PMID 28361097, PMID 31883529, PMID 39819934

NIH funding

U54NS065768 (1)